Add like
Add dislike
Add to saved papers

Translating Glycated Hemoglobin A1c into Time Spent in Glucose Target Range: a Multicenter Study.

Pediatric Diabetes 2019 January 17
BACKGROUND: Approximately 90% of children and adolescents with type 1 diabetes in Sweden use continuous glucose monitoring (CGM), either as real-time CGM or intermittently scanned CGM to monitor their glucose levels. Time in target range (TIT) is an easily understandable metric for assessing glycemic control.

OBJECTIVE: The aim of this study was to examine the relation between TIT and HbA1c.

SUBJECTS AND METHODS: Subjects were recruited from 3 diabetes care centers in Sweden. Glucose data were collected for 133 children and adolescents with type 1 diabetes through CGM using Diasend®. Subjects with registration time over 80% were included in the analysis. HbA1c was collected from SWEDIABKIDS, the Swedish pediatric diabetes quality registry. TIT was defined as 3.9-7.8 mmol/L (70-140 mg/dL) and time in range (TIR) as 3.9-10 mmol/L (70-180 mg/dL).

RESULTS: During a period of 60 days, 105 subjects provided complete data for analysis. Mean age was 12.2 (± 3.3) years, mean HbA1c was 53.9 (± 8.2) mmol/mol or 7.1% (± 0.7%). Mean sensor glucose value was 8.6 (± 1.3) mmol/L, mean coefficient of variation was 42.2% (± 7.2%), mean TIT was 40.9% (± SD 12.2%), and mean TIR was 60.8% (± 13.1%). There was a significant nonlinear relation between TIT during 60 days and HbA1c, R2 = 0.69.

CONCLUSION: This study suggests a nonlinear relation between time spent in glucose target range and HbA1c. The finding implies that time spent in TIT could be a useful metric in addition to HbA1c to assess glycemic control. This article is protected by copyright. All rights reserved.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app